Hemodiyaliz Hastalarında Düzenli Aşı Takvimi Kullanımı ve Farkındalıkları

Yıl 2020, , 10 - 15, 31.01.2020

Eylem Topbaş , Buğra Burak Turan Hakan Bay Ahmet Hüdai Emir Umut Çıtlak Tuğba Kavalalı Erdoğan

https://doi.org/10.47565/ndthdt.2020.1

Öz

Amaç: Hemodiyaliz hastalarında düzenli aşı takviminin kullanılma durumunun,
diyaliz öncesi hepatit B aşısını yaptırma durumunun ve hastaların bu konudaki
farkındalığının belirlenmesi amacı ile yapılmıştır.

Metot: Tanımlayıcı nitelikte olan bu çalışmanın evrenini altı ilde bulunan toplam
26 merkezde tedavi gören hastalar (n=353), örneklemini ise araştırmaya katılmaya
gönüllü hastalar (n=246) oluşturmuştur. Veriler “kişisel bilgi formu” kullanılarak
yüz yüze görüşme yöntemi ile elde edilmiştir.

Bulgular: Yaş ortalaması 57,26 ± 14 olan hastaların, %35,4’ünün grip + hepatit B
aşısını yaptırdığı, %35‘inin sadece hepatit-B aşısı yaptırdığı, %56,9’unun ise
hepatit B aşısını diyalize başlamadan 1-6 yıl önce yaptırdığı tespit edilmiştir.
Hastaların düzenli aşı yaptırma durumu ile yaş, aşı yaptırma konusunda eğitim
alma durumu, hangi aşıları mutlaka yapılmasını bilme durumu arasında
istatistiksel açıdan anlamlı farklılık vardır (p<0.05). Hepatit B aşısını diyalize
başlamadan önce yaptırma durumu ile aşı konusunda eğitim alma durumu ve
eğitimi kimden aldığı arasında istatistiksel açıdan anlamlı farklılık vardır
(p<0.05).

Sonuç: Aşılar konusunda hemşireden eğitim alan grubun aşı yaptırma
oranının ve hepatit B aşısının diyalize başlamadan önce yaptırma oranlarının
yüksek olduğu saptandı. 

Anahtar Kelimeler

Aşı Takvimi, Hemodiyaliz, Hasta, Hemşire

Teşekkür

Verilerin toplanmasında desteği olan Ahmet Hüdai Emir, Umut Çıtlak ve Hakan BAY’a teşekkür ederiz.

Use of Regular Vaccination Schedule in Hemodialysis Patients and Awareness

Öz

Aim: The aim of this study was to determine the extent of use of regular
vaccination schedule, the extent of hepatitis B vaccinations before dialysis and the
awareness of patients on this matter in hemodialysis patients.

Method: The population of this descriptive study consisted of patients treated in a
total of 26 centers in six provinces (n=353), and patients who were willing to
participate in the study (n=246) comprised the sample.

Results: Mean age of the patients was 57.26±14, and 35.4% had an influenza+
hepatitis B vaccine, 35% only had a hepatitis-B vaccine, and 56.9% had a
hepatitis B vaccine 1-6 years before starting to receive dialysis. There was a
statistically significant difference between the status of getting vaccinated
regularly, age, the status of having received training on vaccination, the status of
knowing which vaccines to have (p<0.05). There was a statistically significant
difference between the status of having hepatitis B vaccine before starting dialysis
and the status of having received training on vaccination, and the person who gave
the training (p<0.05).

Conclusion: It was determined that the rate of vaccination of patients from the
group who received training on vaccines from a nurse and the rate of patients who
had Hepatitis B vaccine before starting dialysis were high. 

Anahtar Kelimeler

Vaccination Schedule, Hemodialysis, Patient, Nurse

Kaynakça

• 1. Koşan C. The use of vaccines in chronic dialysis patients. AÜTD 2002; 34: 25-29.
• 2. Kosmadakis G, Albaret J, Correia EDC, Somda F, Aguilera D. Vaccination practices in dialysis patients: A narrative review. In Seminars in Dialysis 2018; 31(5): 507-518.
• 3. Erdoğdu Hİ, Atalay E, Gürsoy G, Canbakan B, Aktürk S, and et al. Factors affecting inadequate response to HBV vaccine in hemodialysis patients: northeast anatolia survey with six hemodialysis centers. Clinical and experimental nephrology 2019; 23(4): 530-536.
• 4. Dimitrov Y, Ducher M, Kribs M, Laurent G, Richter S, and et al. Variables linked to hepatitis B vaccination success in non-dialyzed chronic kidney disease patients: Use of a Bayesian model. Nephrologie & Therapeutique 2019; 15(4): 215-219.
• 5. Fabrizi F, Dixit V, Messa P, Martin P. Meta-analysis: levamisole improves the immune response to hepatitis B vaccine in dialysis patients. Alimentary Pharmacology & Therapeutics 2010; 32(6):756-762.
• 6. Masoodi I, Singh C, Wani IA, Wani MM, Ahmed TI, and et al. Sero conversion of viral hepatitis among end stage renal disease patients on hemodialysis in Kashmir: Results of a prospective study. Open Access Macedonian Journal of Medical Sciences 2019; 7(4): 587-93.
• 7. Geddes C, Lindley E, Duncan N. Renal Association Clinical Practice Guideline on prevention of blood borne virus infection in the renal unit. Nephron Clinical Practice 2011; 118(Suppl 1): c165-c188.
• 8. Guidelines for vaccinating kidney dialysis patients and patients with chronic kidney disease summarized from Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2012. https://www.cdc.gov/vaccines/pubs/dialysis-guide-2012.pdf. Access Date: 01.10.2019
• 9. Guideline for vaccinating kidney dialysis patients and patients with chronic kidney disease, (2015). https://www.cdc.gov/vaccines/pubs/downloads/dialysis-guide-2012.pdf.
• 10. Krueger KM, Ison MG, Ghossein C. Practical guide to vaccination in all stages of CKD, including patients treat,ed by dialysis or kidney transplantation. American Journal of Kidney Diseases 2019; XX(XX)):1-9 doi:10.1053/j.ajkd.2019.06.014 (In pres)
• 11. Guidelines for vaccination in patients with chronic kidney disease. Indian Journal of Nephrology 2016; 26(Suppl 1): 15–S18.
• 12. Tosun S. The changing viral hepatitis epidemiology in our country. ANKEM Derg 2013; 27: 128-134.
• 13. Aghakhani A, Banifazl M, Velayati AA, Eslamifar A, Ramezani A. Occult Hepatitis B virus infection in hemodialysis patients: a concept for consideration. Ther Apher Dial 2012; 16(4): 328-33. doi: 10.1111/j.1744-9987.2012.01072.x.
• 14. Süleymanlar G, Ateş K, Seyahi N. Registry of the nephrology, dialysis and transplantation in Turkey Regisrty 2017. Miki Matbacılık, 2018.
• 15. Chaves SS, Daniels D, Cooper BW, Malo-Schlegel S, Macarthur S, and et al. Immunogenicity of hepatitis B vaccine among hemodialysis patients: effect of revaccination of non-responders and duration of protection. Vaccine 2011; 29 –23.
• 16. Barraclough KA, Wiggins KJ, Hawley CM, van Eps CL, Mudge DW, and et al. Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomised controlled trial in nonresponders to primary vaccination. American Journal of Kidney Diseases 2009; 54: 95–103.
• 17. Tsouchnikas I, Dounousi E, Xanthopoulou K, Papakonstantinou S, Thomoglou V, et al. Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination. Clinical Nephrology 2007; 68(4): 228–34.
• 18. Topbaş E. Kronik böbrek hastalığının önemi, evreleri ve evrelere özgü bakımı. Nefroloji Hemşireliği Dergisi 2015; 10(1): 53-59.
• 19. Jenkins K, Mahon A. Haemodialysis, in: Chronic kidney disease. EDTNA/ERCA, 2008. pp111.
• 20. Duval L, George C, Hedrick N, Woodruff S, Kleinpeter MA. Network 13 partnership to improve the influenza, pneumococcal pneumonia, and hepatitis B vaccination rates among dialysis patients. Advances in Peritoneal Dialysis 2011; 27: 106-111.